• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Thromb Haemost . PAR1 regulation of CXLC1 expression and neutrophil recruitment to the lung in mice infected with influenza A virus

tetano

Editor, Senior Moderator
J Thromb Haemost


. 2020 Dec 21.
doi: 10.1111/jth.15221. Online ahead of print.
PAR1 regulation of CXLC1 expression and neutrophil recruitment to the lung in mice infected with influenza A virus


Silvio Antoniak[SUP] 1 [/SUP], Kohei Tatsumi[SUP] 2 [/SUP], Clare M Schmedes[SUP] 2 [/SUP], Grant J Egnatz[SUP] 2 [/SUP], Alyson C Auriemma[SUP] 2 [/SUP], Vanthana Bharathi[SUP] 2 [/SUP], Tracy Stokol[SUP] 3 [/SUP], Melinda A Beck[SUP] 4 [/SUP], John H Griffin[SUP] 5 [/SUP], Joseph S Palumbo[SUP] 6 [/SUP], Nigel Mackman[SUP] 2 [/SUP]



Affiliations

Abstract

Background: Protease-activate receptor 1 (PAR1) is expressed in various immune cells and in the lung. We showed that PAR1 plays a role in Coxsackievirus B3 infection by enhancing TLR3-dependent interferon-β expression in cardiac fibroblasts.
Objectives: We investigated the role of PAR1 in a mouse model of influenza A virus (IAV) infection.
Methods: We used mice with either a global deficiency of PAR1, cell type-specific deficiencies of PAR1 or mutation of PAR1 at the R41 or R46 cleavage sites.
Results: PAR1 deficient mice had increased CXCL1 expression in the lung, increased neutrophil recruitment, increased protein levels in the bronchoalveolar lavage fluid and increased mortality after IAV infection compared to control mice infected with IAV. Results from mice with cell type-specific deletion of PAR1 indicated that PAR1 expression by hematopoietic cells suppressed CXCL1 expression whereas PAR1 expression by endothelial cells enhanced CXCL1 expression in response to IAV infection. PAR1 activation also enhanced polyinosinic:polycytodylic acid induction of IL-8 in a human endothelial cell line. Mutation of the R46 cleavage site of PAR1 was associated with increased CXCL1 expression in the lung in response to IAV infection, which suggested that R46 signaling suppresses CXCL1 expression.
Conclusions: These results indicate that PAR1 expression by different cell types and activation by different proteases modulates the immune response during IAV infection.

Keywords: CXCL1; Protease-activated receptor 1; biased signaling; influenza A virus; neutrophils.
 
Back
Top Bottom